Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of ...

FDA approval of a Guardant Health blood test that screens for colorectal cancer makes it the first liquid biopsy approved for this type of cancer, clearing the way to make this test more accessible to ...

Multi-cancer early detection tests (MCEDs), sometimes called liquid biopsy tests, are a new method of detecting cancer early. While the concept is promising, these untested tests currently pose ...

A new blood test from Labcorp could potentially help cancer patients begin the most efficient treatments as early as possible. The Plasma Focus liquid biopsy requires only a standard blood draw to run ...

A blood test based on whole-genome sequencing achieved 99% sensitivity and specificity for detecting HPV-positive head and neck cancer. Early postoperative detection of circulating tumor DNA predicted ...

Urine-based testing for patient selection and genomic characterization of patients with FGFR alteration-positive non–muscle-invasive bladder cancer (NMIBC) treated with TAR-210. Effect of neutrophil ...

Hepatocellular carcinoma (HCC) has an increasing incidence and global mortality burden. Diagnosis and management of HCC has improved over the years, and innovative molecular tests are emerging as ...

Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...

A bone marrow biopsy is a medical procedure used to collect a small sample of bone marrow, which is the soft, spongy tissue inside your bones where blood cells are made. This test helps a physician ...

A prostate biopsy is a procedure to remove small samples of tissue from the prostate gland. It's a method to test for prostate cancer if a prostate-specific antigen (PSA) blood test or digital rectal ...